Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: patron_anejo_por_favor who wrote (116747)	8/12/2001 2:59:55 PM
From: Ilaine	Respond to of 436258

>>Neither Mr. Calcagnini nor Mr. Rauch returned phone calls. John Adams, chairman of Adams, Harkness & Hill, said he believed in Mr. Rauch's analysis. Asked if his firm's support of the stock was related to commissions generated by Polymedica insiders' trades, Mr. Adams said getting such orders is customary. "It's a way of saying thank you for the research coverage," he said.<< Holy chit! There's an open-and-shut class action suit right there.-ng- Material misrepresentation in order to achieve financial gain. Maybe breach of fiduciary duty to the firm's clients, as well.